L-162-2016
Agreement ID
L-162-2016
Lead IC
NIAAA
Exclusivity
Exclusive
External Party
Inversago Pharma, Inc
Fiscal Year
2018
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies